TARGETING THE NS5A PROTEIN OF HCV: AN EMERGING OPTION.

TARGETING THE NS5A PROTEIN OF HCV: AN EMERGING OPTION.

Item
http://www.wikidata.org/entity/Q39712899
The crystal structure of NS5A domain 1 from genotype 1a reveals new clues to the mechanism of action for dimeric HCV inhibitorsTherapeutic Potential of Spirooxindoles as Antiviral AgentsExpanding the proteome of an RNA virus by phosphorylation of an intrinsically disordered viral protein.Resistance patterns associated with HCV NS5A inhibitors provide limited insight into drug binding.Approaches to hepatitis C treatment and cure using NS5A inhibitorsThe lysine methyltransferase SMYD3 interacts with hepatitis C virus NS5A and is a negative regulator of viral particle production.Intragenic complementation of hepatitis C virus NS5A RNA replication-defective alleles.Preclinical characterization of GSK2336805, a novel inhibitor of hepatitis C virus replication that selects for resistance in NS5AHCV NS5A dimer interface residues regulate HCV replication by controlling its self-interaction, hyperphosphorylation, subcellular localization and interaction with cyclophilin A
P2860

TARGETING THE NS5A PROTEIN OF HCV: AN EMERGING OPTION.

Item
http://www.wikidata.org/entity/Q39712899
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
TARGETING THE NS5A PROTEIN OF HCV: AN EMERGING OPTION.
@en
TARGETING THE NS5A PROTEIN OF HCV: AN EMERGING OPTION.
@nl
type
label
TARGETING THE NS5A PROTEIN OF HCV: AN EMERGING OPTION.
@en
TARGETING THE NS5A PROTEIN OF HCV: AN EMERGING OPTION.
@nl
prefLabel
TARGETING THE NS5A PROTEIN OF HCV: AN EMERGING OPTION.
@en
TARGETING THE NS5A PROTEIN OF HCV: AN EMERGING OPTION.
@nl
P1433
P1476
P2093
P2860
P304
P31
P433
P478
P577
P698
P932
P1433
P1476
TARGETING THE NS5A PROTEIN OF HCV: AN EMERGING OPTION.
@en
P2093
P2860
P304
P31
P433
P478
P577
P698
P932